Is Aimei Health Technology Co., Ltd (AFJK) a Buy, Sell, or Hold?
NASDAQ : AFJK
Aimei Health Technology Co., Ltd — News
$12 USD
$0 (0.0%)
- Volume
- 17.79K
- Average Volume
- 11.43K
- Market Capitalization
- $73.46M
- P/E Ratio
- 71.60
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $130.37
- Year Low
- $6.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
| Source | Headline |
|---|---|
|
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co. , Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the "Company") announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. globenewswire.com - 2026-07-08 17:00:00 |
|
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto. globenewswire.com - 2026-07-08 17:00:00 |
|
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (the "Company") (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the "Quarterly Report") with the U. globenewswire.com - 2026-05-20 16:05:00 |
|
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Quarterly Report was due on May 15, 2026. globenewswire.com - 2026-05-20 16:05:00 |
